Axsome Therapeutics AXSM Geographic — Revenue
Discontinued — last reported Q2 '23
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Axsome Therapeutics’s 10-Q, filed August 7, 2023, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's geographic — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's geographic — revenue?
- Axsome Therapeutics (AXSM) reported geographic — revenue of $600K in Q2 2023.
- How has Axsome Therapeutics's geographic — revenue changed year-over-year?
- Axsome Therapeutics's geographic — revenue increased by 166.7% year-over-year, from $225K to $600K.
- What does geographic — revenue mean?
- The total revenue earned from sales and operations conducted in countries outside the company's home market.
- How do you interpret geographic — revenue?
- An increase indicates successful international market penetration and growing global demand for the company's CNS therapies, while a decrease may suggest regulatory hurdles, pricing pressures, or challenges in establishing international distribution channels.
- How does geographic — revenue compare across companies?
- For biopharmaceutical companies, international revenue is often compared against regional peers or global pharmaceutical leaders to gauge the success of overseas commercialization efforts and regulatory approval timelines.